Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT00773318
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically proven prostate cancer
* Initial staging (Bone scan, CT, or MRI) according to the NCCN guidelines
* Patients with AJCC stages I - II - III prostate cancer including men with clinical T3N0M0 disease, men with PSA \> 10 mg/ml, and men with Gleason score of 8-10 (high grade disease)
* Prostate cancer patients will be scheduled for prostatectomy and pelvic lymph node dissection
* Informed consent signed by the patient
Exclusion Criteria:
* Patients with no histological evidence of prostate cancer
* Patient with regionally advanced disease or metastatic disease (T4, and/or N1, and/or M1)
* Patients with clinically and/or radiologically evident regional lymph node metastases
* Patients who are not scheduled for radical prostatectomy and pelvic lymph node dissection
* Patients with physical and/or psychological contraindications
* Recent studies in Nuclear Medicine with long half-time isotopes (i.e. T ½ \> 48h; 111In, 67Ga, 201Tl, 131I) performed within 1 week preceding the LM/SL
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00773318
Study Brief:
Protocol Section:
NCT00773318